• Opinion
• The Minister should be appointed to lead policy continuity
• by Lee, Hye-Kyung May 20, 2022 06:11am

• Opinion
• [Reporter’s View] New govnt signals expanded PE exemptions
• by Eo, Yun-Ho May 18, 2022 05:52am

• Opinion
• [Reporter’s View] Now is the time for drug reclassification
• by Lee, Tak-Sun May 6, 2022 05:46am

• Opinion
• [Reporter’s View] Use of maintenance and adjuvant therapies
• by Eo, Yun-Ho May 4, 2022 06:03am

• Opinion
• [Reporter’s View]Recall the purpose of regulating biologics
• by Apr 27, 2022 06:04am

• Opinion
• [Reporter’s View] 1st oral abortion pill approval difficult
• by Lee, Hye-Kyung Apr 21, 2022 06:03am

• Opinion
• [Reporter’s View] Patience is a virtue...for drugs?
• by Eo, Yun-Ho Apr 20, 2022 06:05am

• Opinion
• [Desk] R&D capabilities and Moonshot
• by Chon, Seung-Hyun Apr 19, 2022 05:52am

• Opinion
• [Reporter's eyes] Despite Tessentrick's high sales
• by Apr 15, 2022 06:03am

• Opinion
• [Reporter’s View] Deleting exemptions for industry dev.
• by Lee, Jeong-Hwan Apr 7, 2022 06:10am